My Quote Request
No products added yet
6505-01-577-5940
20 Products
NDC66521-0200-02
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015775940
NSN
6505-01-577-5940
MFG
NOVARTIS VACCINES AND DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML PREFILLED SYRINGE 10S
SPECIAL FEATURES: MONOVALENT; 0.5 ML PREFILLED, SINGLE DOSE SYRINGE; 10 PER PACKAGE; FOR IMMUNIZATION OF PERSONS 4 YEARS OF AGE AND OLDER; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; DO NOT FREEZE
Related Searches:
6505NCM093875
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015775940
NSN
6505-01-577-5940
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML PREFILLED SYRINGE 10S
SPECIAL FEATURES: MONOVALENT; 0.5 ML PREFILLED, SINGLE DOSE SYRINGE; 10 PER PACKAGE; FOR IMMUNIZATION OF PERSONS 4 YEARS OF AGE AND OLDER; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; DO NOT FREEZE
Related Searches:
H1N1 VACCINE
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015775940
NSN
6505-01-577-5940
MFG
NOVARTIS VACCINES AND DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML PREFILLED SYRINGE 10S
SPECIAL FEATURES: MONOVALENT; 0.5 ML PREFILLED, SINGLE DOSE SYRINGE; 10 PER PACKAGE; FOR IMMUNIZATION OF PERSONS 4 YEARS OF AGE AND OLDER; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; DO NOT FREEZE
Related Searches:
13840
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
13840
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN CONCENTRATE FOR INJ 400MG 40ML
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 10MG CIPROFLOXACIN PER ML; 400MG/40 ML SINGLE DOSE VIAL; PRTOECT FROM LIGHT AND FROM FREEZING; USED ONLY TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; CONCENTRATE
Related Searches:
6505NCM093859
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
6505NCM093859
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN CONCENTRATE FOR INJ 400MG 40ML
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 10MG CIPROFLOXACIN PER ML; 400MG/40 ML SINGLE DOSE VIAL; PRTOECT FROM LIGHT AND FROM FREEZING; USED ONLY TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; CONCENTRATE
Related Searches:
CIPROFLOXACIN
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
CIPROFLOXACIN
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
MFG
HOSPIRA INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN CONCENTRATE FOR INJ 400MG 40ML
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 10MG CIPROFLOXACIN PER ML; 400MG/40 ML SINGLE DOSE VIAL; PRTOECT FROM LIGHT AND FROM FREEZING; USED ONLY TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; CONCENTRATE
Related Searches:
NDC00409-4778-86
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
NDC00409-4778-86
CIPROFLOXACIN CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505015776179
NSN
6505-01-577-6179
MFG
HOSPIRA INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN CONCENTRATE FOR INJ 400MG 40ML
III PROTECTIVE STORAGE FEATURE: REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 10MG CIPROFLOXACIN PER ML; 400MG/40 ML SINGLE DOSE VIAL; PRTOECT FROM LIGHT AND FROM FREEZING; USED ONLY TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; CONCENTRATE
Related Searches:
14085
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776430
NSN
6505-01-577-6430
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML SINGLEDOSE VI 10S
SPECIAL FEATURES: MONOVALENT; 0.5ML SINGLE DOSE VIAL; TEN VIALS; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C (36-46 DEG.F); DO NOT FREEZE; FOR AGES 6 MONTHS AND UP
Related Searches:
6505NCM093924
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776430
NSN
6505-01-577-6430
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML SINGLEDOSE VI 10S
SPECIAL FEATURES: MONOVALENT; 0.5ML SINGLE DOSE VIAL; TEN VIALS; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C (36-46 DEG.F); DO NOT FREEZE; FOR AGES 6 MONTHS AND UP
Related Searches:
H1N1 VACCINE 0.5ML SDV
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776430
NSN
6505-01-577-6430
H1N1 VACCINE 0.5ML SDV
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776430
NSN
6505-01-577-6430
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML SINGLEDOSE VI 10S
SPECIAL FEATURES: MONOVALENT; 0.5ML SINGLE DOSE VIAL; TEN VIALS; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C (36-46 DEG.F); DO NOT FREEZE; FOR AGES 6 MONTHS AND UP
Related Searches:
NDC49281-0650-10
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776430
NSN
6505-01-577-6430
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE A H1N1 0.5ML SINGLEDOSE VI 10S
SPECIAL FEATURES: MONOVALENT; 0.5ML SINGLE DOSE VIAL; TEN VIALS; FOR IM USE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C (36-46 DEG.F); DO NOT FREEZE; FOR AGES 6 MONTHS AND UP
Related Searches:
14084
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776829
NSN
6505-01-577-6829
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PEDIATRIC .25ML PREFILLED SYR SD W/O NEEDLE 10S
SPECIAL FEATURES: MONOVALENT; PEDIATRIC; .25ML PREFILLED SINGLE DOSE SYRINGE; 10 SYRINGES PER PKG; FOR IM USE; REQUIRES REFRIG BTWN 2-8 DEG.C; DO NOT FREEZE; WITHOUT NEEDLE; FOR 6 MONTHS THRU 35 MONTHS OF AGE, AND FOR 2-49 YEARS OF AGE
Related Searches:
6505NCM093876
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776829
NSN
6505-01-577-6829
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PEDIATRIC .25ML PREFILLED SYR SD W/O NEEDLE 10S
SPECIAL FEATURES: MONOVALENT; PEDIATRIC; .25ML PREFILLED SINGLE DOSE SYRINGE; 10 SYRINGES PER PKG; FOR IM USE; REQUIRES REFRIG BTWN 2-8 DEG.C; DO NOT FREEZE; WITHOUT NEEDLE; FOR 6 MONTHS THRU 35 MONTHS OF AGE, AND FOR 2-49 YEARS OF AGE
Related Searches:
H1N1 PEDIATRIC
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776829
NSN
6505-01-577-6829
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PEDIATRIC .25ML PREFILLED SYR SD W/O NEEDLE 10S
SPECIAL FEATURES: MONOVALENT; PEDIATRIC; .25ML PREFILLED SINGLE DOSE SYRINGE; 10 SYRINGES PER PKG; FOR IM USE; REQUIRES REFRIG BTWN 2-8 DEG.C; DO NOT FREEZE; WITHOUT NEEDLE; FOR 6 MONTHS THRU 35 MONTHS OF AGE, AND FOR 2-49 YEARS OF AGE
Related Searches:
NDC49281-0650-25
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776829
NSN
6505-01-577-6829
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PEDIATRIC .25ML PREFILLED SYR SD W/O NEEDLE 10S
SPECIAL FEATURES: MONOVALENT; PEDIATRIC; .25ML PREFILLED SINGLE DOSE SYRINGE; 10 SYRINGES PER PKG; FOR IM USE; REQUIRES REFRIG BTWN 2-8 DEG.C; DO NOT FREEZE; WITHOUT NEEDLE; FOR 6 MONTHS THRU 35 MONTHS OF AGE, AND FOR 2-49 YEARS OF AGE
Related Searches:
13598
ESOMEPRAZOLE MAGNES
NSN, MFG P/N
6505015776840
NSN
6505-01-577-6840
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES 20MG BT 1000S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 20 MG ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES; 1000 CAPSULES PER BOTTLE; ORAL ADMINISTRATION; USED TO MAINTAIN SYMPTOM RESOLUTION AND HEALING OF EROSIVE ESOPHAGITIS; INDICATED FOR THE TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD;
~1: STORE AT CONTROLLED ROOM TEMPERATURE
Related Searches:
6505NCM093806
ESOMEPRAZOLE MAGNES
NSN, MFG P/N
6505015776840
NSN
6505-01-577-6840
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES 20MG BT 1000S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 20 MG ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES; 1000 CAPSULES PER BOTTLE; ORAL ADMINISTRATION; USED TO MAINTAIN SYMPTOM RESOLUTION AND HEALING OF EROSIVE ESOPHAGITIS; INDICATED FOR THE TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD;
~1: STORE AT CONTROLLED ROOM TEMPERATURE
Related Searches:
NDC00186-5020-82
ESOMEPRAZOLE MAGNES
NSN, MFG P/N
6505015776840
NSN
6505-01-577-6840
MFG
ASTRAZENECA PHARMACEUTICALS LP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES 20MG BT 1000S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 20 MG ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES; 1000 CAPSULES PER BOTTLE; ORAL ADMINISTRATION; USED TO MAINTAIN SYMPTOM RESOLUTION AND HEALING OF EROSIVE ESOPHAGITIS; INDICATED FOR THE TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD;
~1: STORE AT CONTROLLED ROOM TEMPERATURE
Related Searches:
NEXIUM DELAYED RELEASE CAPSULE
ESOMEPRAZOLE MAGNES
NSN, MFG P/N
6505015776840
NSN
6505-01-577-6840
NEXIUM DELAYED RELEASE CAPSULE
ESOMEPRAZOLE MAGNES
NSN, MFG P/N
6505015776840
NSN
6505-01-577-6840
MFG
ASTRAZENECA PHARMACEUTICALS LP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES 20MG BT 1000S
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 20 MG ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES; 1000 CAPSULES PER BOTTLE; ORAL ADMINISTRATION; USED TO MAINTAIN SYMPTOM RESOLUTION AND HEALING OF EROSIVE ESOPHAGITIS; INDICATED FOR THE TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD;
~1: STORE AT CONTROLLED ROOM TEMPERATURE
14092
INFLUENZA VIRUS VAC
NSN, MFG P/N
6505015776965
NSN
6505-01-577-6965
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PEDIATRICH1N1 VACCINE .25ML PREFILLED SINGLE DOSE SYRINGE 10S
III SUPPLEMENTARY FEATURES: PEDIATRIC; .25ML PREFILLED SINGLE DOSE SYRINGE; 10 SYRINGES PER PKG; FOR IM USE; REQUIRES REFRIG BTWN 2-8 DEG.C
SPECIAL FEATURES: DO NOT FREEZE
